Ensign Group Inc
F:EGB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Ensign Group Inc
F:EGB
|
US |
|
Y
|
Yum China Holdings Inc
HKEX:9987
|
CN |
|
E
|
Energy SpA
MIL:ENY
|
IT |
|
D
|
Deutsche Telekom AG
SWB:DTE
|
DE |
|
N
|
NRJ Group SA
XBER:NR8
|
FR |
|
Grupo Aeroportuario del Pacifico SAB de CV
NYSE:PAC
|
MX |
|
C
|
ConvaTec Group PLC
OTC:CNVVF
|
UK |
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
C
|
Coloplast A/S
SWB:CBHD
|
DK |
|
Ternium SA
NYSE:TX
|
LU |
|
C
|
Compagnie de Saint Gobain SA
XHAM:GOB
|
FR |
|
Titan Company Ltd
NSE:TITAN
|
IN |
|
K
|
Kimberly-Clark Corp
SWB:KMY
|
US |
Ensign Group Inc
Ensign Group is a healthcare company that owns, leases, and manages skilled nursing facilities, assisted living and senior living communities, and related rehab and therapy services. Its core business is caring for older adults and patients who need short-term recovery or long-term nursing support after a hospital stay, illness, or injury. It also provides home health, hospice, and therapy services in some markets, which lets it follow patients through different stages of care. The company makes money mainly from patient care payments tied to these facilities and services, with reimbursement coming from government healthcare programs, private insurers, and patients or families when appropriate. In some cases, Ensign also earns fees by managing facilities it does not own outright or by leasing buildings to operators. That mix of ownership, operations, and real estate gives it more control over how care is delivered than a plain hospital operator or a simple landlord. What makes Ensign different is that it sits in the middle of the post-acute care system, where patients often move from the hospital to a nursing or rehab setting before going home. That role gives it a steady need for services tied to aging and recovery, and it can earn money from both day-to-day care and the facilities themselves. For beginner investors, it is best understood as a healthcare services and senior care operator with a strong focus on post-hospital recovery and long-term nursing care.
Ensign Group is a healthcare company that owns, leases, and manages skilled nursing facilities, assisted living and senior living communities, and related rehab and therapy services. Its core business is caring for older adults and patients who need short-term recovery or long-term nursing support after a hospital stay, illness, or injury. It also provides home health, hospice, and therapy services in some markets, which lets it follow patients through different stages of care.
The company makes money mainly from patient care payments tied to these facilities and services, with reimbursement coming from government healthcare programs, private insurers, and patients or families when appropriate. In some cases, Ensign also earns fees by managing facilities it does not own outright or by leasing buildings to operators. That mix of ownership, operations, and real estate gives it more control over how care is delivered than a plain hospital operator or a simple landlord.
What makes Ensign different is that it sits in the middle of the post-acute care system, where patients often move from the hospital to a nursing or rehab setting before going home. That role gives it a steady need for services tied to aging and recovery, and it can earn money from both day-to-day care and the facilities themselves. For beginner investors, it is best understood as a healthcare services and senior care operator with a strong focus on post-hospital recovery and long-term nursing care.
Record occupancy: Ensign said same-store and transitioning occupancy hit new highs of 84.3% and 85.1%, and management emphasized that demand for skilled nursing remains strong despite recent market noise around managed care.
Guidance raised: The company lifted full-year 2026 EPS guidance to $7.48 to $7.62 from $7.41 to $7.61 and revenue guidance to $5.81 billion to $5.86 billion from $5.77 billion to $5.84 billion.
Strong quarter: First-quarter GAAP diluted EPS was $1.67, up 21.9%, on revenue of $1.4 billion, up 18.4%, with net income of $99.7 million.
Acquisition engine: Ensign added 22 new operations during the quarter and since, and said its pipeline includes more mid-sized regional portfolios, with several additions expected in Q2 and Q3.
Clinical debate: Management pushed back on concerns about heightened clinical review or a broad slowdown in demand, saying it is seeing higher-acuity patients rather than fewer patients.
Balance sheet: The company said it ended the quarter with $539.5 million in cash, more than $592 million of available credit capacity, and a lease-adjusted net debt-to-EBITDA ratio of 1.73x.